Skip to main content
. 2020 Jan 21;2020:6387545. doi: 10.1155/2020/6387545

Figure 1.

Figure 1

KIF22 is overexpressed in TSCC and associated with poor prognosis. (a) Representative images of KIF22 expression level in patients with TSCC by immunohistochemical staining. The expression level of KIF22 was different in patients. (b) Immunohistochemical staining of KIF22 in adjacent normal tissues. (c) Overall survival rate and disease-free survival rate of patients with a high or low expression level of KIF22, respectively.